Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addentax (ATXG) Accumulated Expenses (2017 - 2025)

Addentax has reported Accumulated Expenses over the past 9 years, most recently at $280814.0 for Q4 2025.

  • Quarterly Accumulated Expenses fell 75.61% to $280814.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $280814.0 through Dec 2025, down 75.61% year-over-year, with the annual reading at $1.9 million for FY2025, 1905.44% up from the prior year.
  • Accumulated Expenses was $280814.0 for Q4 2025 at Addentax, up from $267278.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $2.8 million in Q4 2022 and troughed at $78776.0 in Q1 2022.
  • The 5-year median for Accumulated Expenses is $771643.5 (2021), against an average of $1.0 million.
  • Year-over-year, Accumulated Expenses plummeted 84.73% in 2024 and then soared 1905.44% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $778260.0 in 2021, then soared by 254.66% to $2.8 million in 2022, then tumbled by 54.65% to $1.3 million in 2023, then decreased by 8.04% to $1.2 million in 2024, then plummeted by 75.61% to $280814.0 in 2025.
  • Per Business Quant, the three most recent readings for ATXG's Accumulated Expenses are $280814.0 (Q4 2025), $267278.0 (Q3 2025), and $2.1 million (Q2 2025).